Suppr超能文献

[恰帕斯州先天性心脏病的干预治疗。千例手术之后的历程]

[Interventionism in congenital heart disease in Chiapas. The history after thousand cases performed].

作者信息

Mijangos-Vázquez Roberto, Hernández-Reyes Rogelio

机构信息

Departamento de Cardiología Intervencionista Pediátrica, Hospital de Especialidades Pediátricas, Universidad Autónoma de Chiapas, Tuxtla Gutiérrez, Chiapas, México.

出版信息

Arch Cardiol Mex. 2024 Feb 1;94(3):300-308. doi: 10.24875/ACM.23000170.

Abstract

BACKGROUND

Congenital heart disease is the most common birth defect and the leading cause of childhood mortality in high-income countries. In these countries, the prognosis for a child born with congenital heart disease is excellent, with over 90% achieving adulthood. However, in the low and lower-middle-income countries, as ours, the outlook is starkly different. In Chiapas, because of the progress of the hemodynamics program, more and more types of congenital heart diseases are susceptible to being treated by cardiac catheterization.

OBJECTIVE

To show the global experience of the interventionism in congenital heart diseases in Chiapas from its inception to recent days.

METHOD

Through a retrospective study from April 2016 to June 2023, we reviewed the electronic files of the total of patients who underwent cardiac catheterism during the same period of time.

RESULTS

A total of 1000 procedures were performed, 581 in female patients, with a median age of 4 years (1 day to 77 years). Of the total procedures, 115 (11.5%) were diagnostic catheterizations and 885 (88.5%) were interventional.

CONCLUSIONS

Cardiac catheterization in pediatrics in Chiapas has displaced cardiac surgery in a large percentage, and the results that have been obtained are undoubtedly encouraging, which already represents a decentralization in the care of congenital heart diseases in our country.

摘要

背景

先天性心脏病是最常见的出生缺陷,也是高收入国家儿童死亡的主要原因。在这些国家,患有先天性心脏病的儿童预后良好,超过90%能活到成年。然而,在低收入和中低收入国家,比如我们国家,情况却截然不同。在恰帕斯州,由于血流动力学项目的进展,越来越多类型的先天性心脏病可以通过心导管插入术进行治疗。

目的

展示恰帕斯州从先天性心脏病干预治疗开始至今的全球经验。

方法

通过对2016年4月至2023年6月的回顾性研究,我们查阅了同期接受心导管插入术患者的电子病历。

结果

共进行了1000例手术,其中女性患者581例,中位年龄4岁(1天至77岁)。在所有手术中,115例(11.5%)为诊断性心导管插入术,885例(88.5%)为介入性手术。

结论

恰帕斯州儿科的心导管插入术在很大程度上取代了心脏手术,所取得的结果无疑令人鼓舞,这已经代表了我国先天性心脏病护理的一种去中心化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c39f/11259429/572785f1b3d9/10125AMEX243-ACM-94-300-g001.jpg

相似文献

1
[Interventionism in congenital heart disease in Chiapas. The history after thousand cases performed].
Arch Cardiol Mex. 2024 Feb 1;94(3):300-308. doi: 10.24875/ACM.23000170.
3
Outcomes following cardiac catheterization after congenital heart surgery.
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):622-8. doi: 10.1002/ccd.25490. Epub 2014 Jun 17.
4
Cardiac catheterization in the early post-operative period after congenital cardiac surgery.
JACC Cardiovasc Interv. 2014 Dec;7(12):1437-43. doi: 10.1016/j.jcin.2014.06.022.
5
Catheterization Performed in the Early Postoperative Period After Congenital Heart Surgery in Children.
Pediatr Cardiol. 2019 Apr;40(4):827-833. doi: 10.1007/s00246-019-02078-3. Epub 2019 Mar 4.
6
Transseptal puncture using surgical electrocautery in children and adults with and without complex congenital heart disease.
Catheter Cardiovasc Interv. 2017 Sep 1;90(3):E46-E54. doi: 10.1002/ccd.27202. Epub 2017 Aug 2.
7
Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality.
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):104-10. doi: 10.1002/ccd.25683. Epub 2014 Oct 7.
8
Conotruncal Heart Defect Repair in Sub-Saharan Africa: Remarkable Outcomes Despite Poor Access to Treatment.
World J Pediatr Congenit Heart Surg. 2016 Sep;7(5):592-9. doi: 10.1177/2150135116648309.
9
Hybrid interventional procedures in congenital heart disease.
Methodist Debakey Cardiovasc J. 2014 Apr-Jun;10(2):93-8. doi: 10.14797/mdcj-10-2-93.
10
Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization: A Report From the NCDR IMPACT Registry.
Circulation. 2015 Nov 17;132(20):1863-70. doi: 10.1161/CIRCULATIONAHA.114.014694. Epub 2015 Oct 19.

本文引用的文献

1
Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
Cureus. 2023 Jun 8;15(6):e40132. doi: 10.7759/cureus.40132. eCollection 2023 Jun.
4
Prevalence of Congenital Heart Disease at Live Birth in China.
J Pediatr. 2019 Jan;204:53-58. doi: 10.1016/j.jpeds.2018.08.040. Epub 2018 Sep 27.
5
Procedural Success and Adverse Events in Pulmonary Artery Stenting: Insights From the NCDR.
J Am Coll Cardiol. 2016 Mar 22;67(11):1327-35. doi: 10.1016/j.jacc.2016.01.025.
6
Percutaneous Closure of Perimembranous Ventricular Septal Defects Using the Second-Generation Amplatzer Vascular Occluders.
Am J Cardiol. 2016 Jan 1;117(1):127-30. doi: 10.1016/j.amjcard.2015.10.010. Epub 2015 Oct 17.
8
[Congenital heart disease in Mexico. Regionalization proposal].
Arch Cardiol Mex. 2010 Apr-Jun;80(2):133-40.
9
Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients.
Am Heart J. 2008 Oct;156(4):706-12. doi: 10.1016/j.ahj.2008.06.008. Epub 2008 Jul 30.
10
Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Am J Cardiol. 2005 Dec 19;96(12A):52L-58L. doi: 10.1016/j.amjcard.2005.09.068. Epub 2005 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验